Symrise has acquired extra shares in the probiotic products manufacturer.
Symrise AG (Holzminden, Germany) has acquired extra shares in probiotic developer Probi AB (Lund, Sweden) and is now required to make a public offer for the company’s remaining shares.
A flavor and fragrance specialist, Symrise first took interest in Probi when the two companies entered a joint venture in December 2012, encompassing innovative projects relating to consumer categories such as oral health. Probi is responsible for developing a number of consumer product lines, including GoodBelly and ProViva probiotic beverages.
At the time, Symrise held 15% of Probi’s shares. It is now clear that Symrise has significantly stronger interest in probiotics.
“The globally recognized know-how of Symrise in sensory, active ingredients, and applications combined with Probi’s long-standing and proprietary expertise in patented probiotics will allow us to develop new consumer products with real health benefits and sensory profiles without compromises,” said Probi CEO Michael Oredsson.
Driving Sustainability in Nutraceuticals: How Ingredient Brands Are Raising the Bar
April 26th 2024Health-minded consumers, especially Generation Z, value nutraceutical companies with sustainability embedded into their corporate philosophy—from product development to packaging. This article discusses how responsible companies are responding to the consumer call for greater sustainability by implementing environmentally friendly manufacturing practices that ultimately lead to waste reduction, improved supplier communications and lower supply chain risk. Those who have taken steps to demonstrate a genuine commitment to sustainability are standing out with improved outcomes for all.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.